AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

NAPROXEN SODIUM

7 registrations across 4 African markets— 5 active

Markets with NAPROXEN SODIUM

🇿🇦South Africa
4 registrations
3 active
🇰🇪Kenya
1 registration
1 active
🇲🇼Malawi
1 registration
0 active
🇷🇼Rwanda
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ALEVE
TABLETS
🇷🇼RwandaBayer Bitterfeld GmbHactiveFeb 2030
Synflex Tablet 550mg
Coated Tablet
🇰🇪KenyaMARTIN DOW LIMITEDactiveMar 2028
GAREC-NAPROXEN SODIUM 275 mg🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
NAPROGEN 275MG TABLET
TABLET
🇲🇼Malawi—expiredJul 2002
SYNFLEX 550🇿🇦South AfricaAscendis Pharma (Pty) LtdactiveJan 1900
GO PAIN NAPROXEN 275🇿🇦South AfricaPharmacorp (Pty) LtdactiveJan 1900
SYNFLEX 275🇿🇦South AfricaAscendis Pharma (Pty) LtdactiveJan 1900

NAPROXEN SODIUM in Africa — Regulatory Overview

NAPROXEN SODIUM is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.